Kevin Lee Freeman
Chief Commercial Officer · Health Catalyst, Inc.
- 2024
- Dec 3, 2025
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Kevin Lee Freeman files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Simeon Kohl - $105K in HCAT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Kevin Lee Freeman?
Kevin Lee Freeman is a corporate insider, tracked as Chief Commercial Officer of Health Catalyst, Inc. (HCAT). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Kevin Lee Freeman last file a Form 4?
The most recent primary Form 4 on record is dated 3 December 2025, one of 3 filings going back to 2024.
Has Kevin Lee Freeman been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($67K) across all tracked filings.
